Anke Seegebarth
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
-
- Neonatal Respiratory Health Research 5
- Cystic Fibrosis Research Advances 1
- Co-authors
- Bernd Schmidt (4 shared papers)Christoph Kneip (4 shared papers)Dimo Dietrich (4 shared papers)Michael Fleischhacker (4 shared papers)Volker Liebenberg (4 shared papers)Sabine Weickmann (3 shared papers)John K. Field (2 shared papers)Thomas Schlegel (2 shared papers)
- Journals
- BMC Cancer (2 papers)PLoS Pathogens (1 paper)Journal of Thoracic Oncology (1 paper)Gut (1 paper)BioTechniques (1 paper)
- Partner nations
- GermanyUnited KingdomCanada
In The Last Decade
Anke Seegebarth
9 papers receiving 474 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 183
- Molecular Biology 335
- Pulmonary and Respiratory Medicine 149
- Gastroenterology 15
- Oncology 72
Countries citing papers authored by Anke Seegebarth
This map shows the geographic impact of Anke Seegebarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Seegebarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Seegebarth more than expected).
Fields of papers citing papers by Anke Seegebarth
This network shows the impact of papers produced by Anke Seegebarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Seegebarth. The network helps show where Anke Seegebarth may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Seegebarth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 191 | |
| 2 | 2010 | 150 | |
| 3 | 2011 | 58 | |
| 4 | 2017 | 24 | |
| 5 | 2015 | 19 | |
| 6 | 2024 | 16 | |
| 7 | 2009 | 13 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 4 |
About Anke Seegebarth
Anke Seegebarth is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology, Immunology and Surgery, having authored 9 papers that have together received 480 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Neonatal Respiratory Health Research (5 papers), RNA modifications and cancer (3 papers), Immune Cell Function and Interaction (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Cystic Fibrosis Research Advances (1 paper), Celiac Disease Research and Management (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Cancer Research (183 citations), Molecular Biology (335 citations), Pulmonary and Respiratory Medicine (149 citations), Gastroenterology (15 citations) and Oncology (72 citations). Anke Seegebarth has collaborated with scholars based in Germany, United Kingdom and Canada. Frequent co-authors include Bernd Schmidt, Christoph Kneip, Dimo Dietrich, Michael Fleischhacker, Volker Liebenberg, Sabine Weickmann, John K. Field, Thomas Schlegel, Jörn Lewin and Christian Witt. Their work appears in journals such as BMC Cancer, PLoS Pathogens, Journal of Thoracic Oncology, Gut and BioTechniques.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.